FIDELION DIAGNOSTICS PTE. LTD. → BioNexus Gene Lab Corp BGLC

Stake: — Shares: — Class: COMMON STOCK, NO PAR VALUE

Composite Decision Signal · AVOID (DILUTION / EXIT TRAP) Conviction Score: 12/100

Disqualifiers: ACTIVE_DILUTION_SHELF: 8-K Item 3.02 unregistered equity sale within [-30d, +5d]

Passive Schedule 13G filer baseline
Material 8-K governance/transaction event (Item 5.02 / 1.01 / 2.01) within ±30d

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-09-30

DTC 1.50

10,111 shares short · -22.4% vs prior

Other 13D/G Filings on BioNexus Gene Lab Corp

Filed	Form	Filer	Stake	Shares
2026-08-14	SCHEDULE 13D	Tan Lee Su-Leng	11.50%	338,709	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →